HealthEquity (HQY) revenue

Revenue · fiscal 2026
$1.31B

HealthEquity (HQY) reported revenue of $1.31B in fiscal 2026 (the year ended January 31, 2026). That is 9.5% higher than the $1.20B of fiscal 2025. Figures as of 18 Nov 2026, 11:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2026
$1.31B
Change on fiscal 2025
+9.5%
Growth, 5 years
+12.4% a year
Growth, 10 years
+26.3% a year
Highest on record
$1.31Bfiscal 2026
Lowest on record
$46.09Mfiscal 2013
Fiscal years on record
142013–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

HealthEquity revenue, in more detail

Over the five fiscal years to 2026 revenue grew at a compound 12.4% a year; over ten years the rate was 26.3% a year. Across the 14 fiscal years on record (2013–2026), the highest was $1.31B in fiscal 2026 and the lowest $46.09M in fiscal 2013.

History · 14 fiscal years

Revenue by fiscal year

HealthEquity revenue, year by year

HealthEquity (HQY) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2026$1.31B 9.5% up
2025$1.20B 20.0% up
2024$999.59M 16.0% up
2023$861.75M 13.9% up
2022$756.56M 3.1% up
2021$733.57M 37.9% up
2020$531.99M 85.2% up
2019$287.24M 25.1% up
2018$229.53M 28.7% up
2017$178.37M 40.7% up
2016$126.79M 44.3% up
2015$87.86M 41.7% up
2014$62.02M 34.6% up
2013$46.09M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of HealthEquity and comparable companies
CompanyRevenueFiscal year
Twist Bioscience TWST$459.43M2026
Protagonist Therapeutics PTGX$46.02M2025
Krystal Biotech KRYS$389.13M2025
10x Genomics TXG$642.82M2025
HealthEquity HQY$1.31B2026
Corcept Therapeutics CORT$761.41M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HQY

HealthEquity, figure by figure

HealthEquity (HQY) overview: price, valuation and scorecardAll health care companies by market value

HealthEquity revenue: questions and answers

What is HealthEquity's revenue?

HealthEquity (HQY) reported revenue of $1.31B in fiscal 2026 (the year ended January 31, 2026). That is 9.5% higher than the $1.20B of fiscal 2025.

What is the growth rate of HealthEquity's revenue?

Over the five fiscal years to 2026 revenue grew at a compound 12.4% a year; over ten years the rate was 26.3% a year.

What are the highest and lowest revenue figures on record for HealthEquity?

Across the 14 fiscal years on record (2013–2026), the highest was $1.31B in fiscal 2026 and the lowest $46.09M in fiscal 2013.

How is HealthEquity's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For HealthEquity it is on record here for 14 fiscal years, 2013 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “HealthEquity (HQY) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/HQY/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.